Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAGIC: Skeletal Myoblast Autologous Grafting in Ischemic Cardiomyopathy
2005-004034-41Phase 2Terminated
- Sponsor
- Sanofi
- Start
- Oct 2005
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 2 trial of cultured autologous skeletal myoblast cells in Ischemic congestive heart failure (ICM-HF) and ischaemic cardiomyopathy (ICM), sponsored by Sanofi. Started Oct 2005; status: terminated.
02
Drugs
cultured autologous skeletal myoblast cells
03
Conditions
Ischemic congestive heart failure (ICM-HF)ischaemic cardiomyopathy (ICM)
Beyond the preview
Go deeper on 2005-004034-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004034-41.